Objective: To review the technical feasibility and effectiveness of N-butyl cyanoacrylate (NBCA; Histoacryl, B. Braun, Melsungen, Germany) 
INTRODUCTION
Transcatheter arterial embolisation has been used for many years to effectively control active arterial haemorrhage and embolise pseudoaneurysms in various conditions and at different anatomical locations. Most often, metallic coils or particulate agents are used to achieve haemostasis in these cases. N-butyl cyanoacrylate (NBCA; Histoacryl, B. Abbreviations: CT = computed tomography; DIC = disseminated intravascular coagulopathy; DHS = dynamic hip screw; Ig = immunoglobulin; NBCA = N-butyl cyanoacrylate; SMA = superior mesenteric artery. * Clinical suspicion of recurrent bleeding.
Braun, Melsungen, Germany), which is a liquid and permanent embolic agent, is an alternative for control of acute arterial haemorrhage and embolisation of pseudoaneurysms.
The purpose of this study was to review the technical feasibility and effectiveness of NBCA embolisation to control acute arterial haemorrhage in extracranial locations.
METHODS

Patient Population
Between March 2009 and March 2014, a total of 50 patients underwent NBCA embolisation at various anatomical locations and for various conditions in a single institution in Hong Kong. Of them, 17 patients with bleeding episodes or pseudoaneurysms in extracranial locations who had presented clinically or been identified on computed tomography (CT) underwent NBCA embolisation (17 procedures in total) for haemorrhage control and were retrospectively reviewed (Table) .
The patients comprised 11 males and six females with a mean age of 58 years (range, 18-81 years). Causes of the acute haemorrhage were recent operation or procedure (n = 9) [ Figures 1 and 2 ], over-warfarinisation (n = 1), recurrent tongue base carcinoma (n = 1), pulmonary tuberculosis (n = 1), cavitary lung mass (n = 1), duodenal ulcer (n = 1), and trauma (n = 1); causes were unknown in two cases. Angiographic evidence of active contrast extravasation, pseudoaneurysm, or both were present in all patients (n = 17, 100%).
The sites embolised included the kidney (n=4) [ Figure 3 ], abdominal or chest wall (n=3), hepatopancreaticobiliary system (n=3), gastrointestinal tract (n=2) [ Figure 4 ], pulmonary system (n=2) [ Figure 5 ], head and neck (n=1) [ Figure 6 ], spleen (n=1), and lower limb (n=1) [ Figure 7 ].
Embolisation Techniques
All procedures were performed via a common femoral F i g u r e 2 . C a s e 1 0 : ( a ) S u p e r i o r m e s e n t e r i c a n g i o g r a m a n d ( b ) superselective arteriography with microcatheter show an abnormal vessel with pseudoaneurysm (arrows) a n d a c t i v e c o n t r a s t extravasation (arrowheads) at a proximal branch of superior mesenteric artery.
(c) Post-embolisation digital s u b t r a c t i o n a n g i o g r a m and (d) angiogram show obliteration of the abnormal vessel and pseudoaneurysm (arrows), with cessation of contrast extravasation.
Normal branch supplying p a r t o f t h e p a n c r e a s i s sacrificed (arrowheads). Normal distal branches are preserved.
(a) (b) (a) (c) (d) (b)
artery approach using a 5-Fr or 6-Fr sheath, except in one patient in whom an 8-Fr long sheath was used for pulmonary artery pseudoaneurysm embolisation. Angiography using various kinds of 5-Fr or 4-Fr selective catheter (such as Cobra and Simmons) was performed with digital subtraction angiography evaluation performed in all patients to visualise the source of bleeding. The catheters were then used to access the site of haemorrhage or pseudoaneurysm. Diagnostic catheter manoeuvres were performed with a 0.035-inch guidewire.
Superselective catheterisation was performed in all patients (100%) with microcatheters and microguidewires, which was advanced as close as possible to the site of haemorrhage or pseudoaneurysm. The microcatheter was placed through the less-selective 5-Fr or 4-Fr outer catheter that served as a guide to provide a stable position in the proximal vessel. This also allowed rapid exchange of microcatheters occluded by NBCA, and enabled check angiography at the proximal vessels to be performed following embolisation. The optional 'flooding technique' can also be used to achieve more distal embolisation, with positive-pressure continuous flush of 5% dextrose solution at the guiding catheter. This will flood the distal circulation with dextrose solution and slow the polymerisation of NBCA, hence allowing deeper penetration for more distal embolisation.
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NBCA was used as an embolic agent in all patients. NBCA alone was used in 9 (53%) of 17 patients but together with other embolic agents (including metallic coils, trisacryl gelatin microspheres, and gelatin sponge) in the remaining eight (47%). NBCA was used as the initial embolic agent when the operator anticipated difficulty in selective placement of the catheter close to or beyond the bleeding site in vessels that were small, tortuous, or anatomically difficult. Bleeding vessels that were supplied by many collateral vessels were also potential candidates for NBCA embolisation. In instances where complete embolisation with other embolic agents (such as coils or particulate agents) failed, additional NBCA could be administered. The decision to use NBCA was predominantly based on the judgement of the operating interventional radiologist(s) at the time of procedure.
NBCA was available in our angiography suite. Consent for transcatheter embolisation was obtained in all patients, though no special consent for NBCA embolisation was obtained. The NBCA was mixed with iodinised oil (Lipiodol; Laboratoire Andre Guerbet, Aulnay-sous-Bois, France) in a ratio of 1:3 to 1:5, dependent on operator's preference. A test injection by hand was performed prior to injection of NBCA mixture to simulate the conditions of the planned embolisation. It was used to assess blood flow and vasculature in the region to prevent non-targeted embolisation, as well as to estimate the volume of mixture required. Clean towels were then placed around the hub of the microcatheter. The microcatheter and injection syringes were flushed with 5% dextrose solution before injection of NBCA to ensure clearance of residual saline or blood that could cause premature polymerisation of the glue within the lumen.
NBCA mixture was subsequently administered under continuous digital subtraction angiogram. The delivery catheter was pulled back slowly after adequate deposition of NBCA mixture at the target site until it was no longer in contact with the column of mixture, and then removed.
Study Endpoints
Retrospective review of patients' clinical records was performed to evaluate the angiographic success, clinical success, embolisation-related complications, and patient outcome.
Angiographic success was defined as absence of contrast extravasation and / or absence of contrast medium entering the pseudoaneurysms on angiography immediately following embolisation.
Complications -including evidence of unintended end-organ damage, abscess formation, and entrapment of delivery catheter -were reviewed in electronic Patient Record. Minor and major complications were defined according to the Classification System of Complications by Outcome in Society of Interventional Radiology Standards of Practice Guideline. 3 NBCA embolisation was considered successful when there was no evidence or suspicion of recurrent bleeding, or no death within 24 hours of the procedure. Suspicion of recurrent bleeding was determined by clinical presentation or change to serial hematocrit levels. Evidence of recurrent bleeding was confirmed by positive radiological or intra-operative findings.
Follow-up was performed until death or discharge for the episode of acute haemorrhage at the latest hospital outpatient visit.
RESULTS
Immediate angiographic success was achieved in all patients (n = 17, 100%), of whom 13 (76.5%) remained in a clinically stable condition without signs or symptoms of recurrent haemorrhage. In the remaining four (23.5%) patients, one had extravasation of contrast and pseudoaneurysm at the gastroduodenal artery (GDA) stump following ampullary carcinoma resection. NBCA embolisation was unsuccessful and emergency laparotomy 3 days later confirmed recurrent bleeding intra-operatively at the GDA stump. Recurrent haemorrhage after NBCA embolisation was clinically suspected in two patients. One of them, who had haemorrhage of a recurrent tongue base carcinoma, showed active contrast extravasation and pseudoaneurysm at the mid right facial artery and had been embolised with microspheres and NBCA resulting in angiographic success. Afterwards, the patient was found to have blood in the endotracheal tube and recurrent bleeding was suspected. He decided to receive supportive care only and succumbed 4 months after admission. Another patient who presented with per rectal bleeding following Whipple procedure for cholangiocarcinoma showed extravasation of contrast from the common hepatic artery, and was subsequently embolised. Nonetheless, the patient presented with recurrent melaena 4 days later although urgent mesenteric angiograms were unremarkable. The fourth patient died within 24 hours of the procedure due to multi-organ failure.
There were no major complications directly related to NBCA embolisation. Non-targeted end-organ embolisation (small splenic infarcts) and suspected liver abscess were evident in one patient on follow-up CT, but the patient was asymptomatic and no additional treatment was given and there were no clinical sequelae. No entrapment of the delivery catheter within the embolised artery occurred during any procedure.
DISCUSSION
Percutaneous transcatheter embolisation has been used for control of arterial haemorrhage and has been shown to be effective in the chest, abdomen, pelvis, and extremities in most patients. [4] [5] [6] Most interventional radiologists are familiar with the use of mechanical agents such as coil or particulate agents, although experience with liquid agents such as adhesives or glues is generally more limited. 7 Many interventional radiologists are reluctant to use liquid adhesives because of the potential risk of complicated ischaemic injury and the difficulty in handling the agent.
8
NBCA is a well-known liquid adhesive used in the vascular system. It was approved in 2000 by the US Food and Drug Administration for use in cerebral arteriovenous malformations (AVMs). Some series have reported clinical success rates of 75% to 100% [8] [9] [10] [11] when the technique has been used in off-label applications, for example, to treat AVMs in peripheral circulation, 12 non-neurologic pseudoaneurysms, 9, 10 and acute arterial haemorrhage at various anatomical locations.
6,9
NBCA has distinct advantages over absolute alcohol, which is another liquid embolisation agent used by some interventional radiologists, in that it does not necessarily permeate to capillary level, and therefore does not inevitably result in tissue infarction. 11 Its low viscosity also allows easy delivery of the agent via a microcatheter.
A disadvantage, however, is that its lack of radiopacity and its rapid polymerisation time make it difficult to use. 8 Mixing it with iodised oil not only opacifies the agent (Figure 3b ) but also slows down the polymerisation time. Pollak and White 7 suggested that the estimated in-vivo polymerisation time for NBCA to iodised oil mixtures of between 1:1 and 1:4 was 1 to 4 seconds, with a linear relationship to the mixture.
Major considerations for choosing an embolic agent are speed and reliability of delivery, duration of occlusive effect, and preservation of normal tissue. Transcatheter embolisation for control of acute haemorrhage is typically performed with metallic coils and / or particulate agents. 13 Nonetheless, selective placement of the catheter close to and beyond the bleeding site, especially in small and tortuous vessels, may be difficult. 9 It is also technically difficult and timeconsuming if the lesion is supplied by many collateral vessels, or if there are many efferent arteries originating from the pseudoaneurysms. 9 NBCA has the advantage of embolising small arteries and collateral circulations that are difficult for metallic coils.
In our case series, angiographic success was achieved in 100% of patients and the overall success rate was 76.5% (13 in 17 patients). Results are comparable with a previously published case series by Kish et al, 11 who reported a 75% success rate (12 out of 16) of NBCA embolisation with or without other embolic agent in patients with acute arterial haemorrhage. Retrospective studies published by Song et al, 10 Jae et al, 8 and Yamakado et al 9 reported an angiographic success rate of 94%, 100%, and 100% for NBCA embolisation in patients with pseudoaneurysms, nonvariceal upper gastrointestinal bleeding, and ruptured pseudoaneurysms, respectively.
Potential complications of transcatheter embolisation with NBCA include end-organ ischaemia (such as bowel infarction in case of embolisation for gastrointestinal haemorrhage), abscess formation, and entrapment of the delivery catheter within the embolised artery.
14-16 Ischaemia, necrosis or ulceration of skin or mucosa is also a possible sequelae of nontarget distal embolisation injury in cases that involve the head and neck or chest wall. The delivery catheter must be removed promptly after each injection to avoid entrapment. Embolisation of untargeted sites or reflux of glue into another innocent vessel by over-injection is also a possible complication of NBCA embolisation. Yamakado et al, 9 Kish et al, 11 Jae et al, 8 and Song et al 10 reported no cases of organ infarction, infectious complications, or catheter entrapment in their case series. In our series, we encountered only one case with evidence of non-targeted end-organ embolisation (small splenic infarcts) and suspected liver abscess at followup CT, and no additional treatment was required and there were no clinical sequelae. No other major endorgan ischaemia, including skin and mucosa of the head and neck or chest wall, was documented in our case series and there was no evidence of catheter entrapment. The results of our cases are comparable with these series.
CONCLUSION
This study demonstrates that NBCA embolisation with or without other embolic agent is technically feasible, effective, and safe to control acute arterial haemorrhage and to embolise pseudoaneurysms due to various causes and at different anatomical locations.
